Home › Neurologic Diseases › Missouri
Neurologic Diseases clinical trials in Missouri
7 studies for Neurologic Diseases are looking for participants at sites in Missouri.
Cities in Missouri
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Citizens Memorial Hospital District, Bolivar
RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Sep 22, 2026 · NCT07589595Product Surveillance Registry
- Columbia
- Kansas City
- St Louis
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- Siteman Cancer Center at Washington University, St Louis
RecruitingPhase 1
36 Months – 22 Years · All sexes · Updated Sep 4, 2026 · NCT03911388Trans-Auricular Stimulation for Postoperative Inflammation in Spine Surgery
- Washington University School of Medicine, St Louis
Recruiting
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07218133Auricular VNS Following Intracerebral Hemorrhage
- Washington University School of Medicine, St Louis
Recruiting
Ages 18 and older · All sexes · Updated Jul 6, 2026 · NCT06799390Rett Syndrome Registry
- Washington University in St. Louis, St Louis
RecruitingObservational study
Ages 0 to 99 · All sexes · Updated Jun 30, 2026 · NCT05432349F 18 T807 Tau PET Imaging of Alzheimer's Disease
- Washington University School of Medicine, St Louis
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 8, 2026 · NCT02414347From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.